Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
89.38
-2.88 (-3.12%)
Apr 25, 2024, 11:51 AM EDT - Market open
Blueprint Medicines Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 81.52 | 124.9 | 215.12 | 689.8 | 119.1 | 73.22 | 404.86 | 53.34 | 164.09 | 47.43 | Upgrade
|
| Short-Term Investments | 639.36 | 825.28 | 267.17 | 187.21 | 369.62 | 425.95 | 273.05 | 162.09 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 720.88 | 950.19 | 482.29 | 877.02 | 488.72 | 499.17 | 677.91 | 215.43 | 164.09 | 47.43 | Upgrade
|
| Cash Growth | -24.13% | 97.02% | -45.01% | 79.45% | -2.09% | -26.37% | 214.68% | 31.28% | 245.97% | 2079.64% | Upgrade
|
| Receivables | 43.18 | 36.94 | 37.03 | 25.31 | 23.41 | 0.22 | 0 | 3.58 | 3.41 | 0 | Upgrade
|
| Inventory | 21.22 | 29.7 | 21.82 | 8.58 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 23.11 | 29.83 | 12.89 | 16.85 | 4.65 | 0.41 | 7.59 | 1.42 | 2.91 | 0.85 | Upgrade
|
| Total Current Assets | 808.39 | 1,047 | 554.03 | 927.76 | 516.79 | 499.79 | 685.51 | 220.43 | 170.42 | 48.27 | Upgrade
|
| Property, Plant & Equipment | 115.65 | 115.2 | 120.86 | 101.67 | 111.11 | 29.63 | 24.36 | 6.19 | 6.66 | 1.48 | Upgrade
|
| Long-Term Investments | 84.32 | 161.27 | 557.53 | 677.87 | 64.41 | 0 | 0 | 54.06 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 40.89 | 26.78 | 19.81 | 11.09 | 15.39 | 10.71 | 5.87 | 2.12 | 1.82 | 0.17 | Upgrade
|
| Total Long-Term Assets | 240.86 | 303.25 | 698.2 | 790.63 | 190.91 | 40.34 | 30.23 | 62.37 | 8.48 | 1.65 | Upgrade
|
| Total Assets | 1,049 | 1,350 | 1,252 | 1,718 | 707.69 | 540.12 | 715.74 | 282.8 | 178.9 | 49.93 | Upgrade
|
| Accounts Payable | 4.71 | 2.73 | 8.33 | 4.37 | 4.79 | 3.3 | 3.74 | 2.21 | 2.46 | 0.81 | Upgrade
|
| Deferred Revenue | 5.6 | 18.29 | 36.58 | 41.16 | 46.07 | 46.17 | 35.37 | 47.24 | 13.64 | 0 | Upgrade
|
| Current Debt | 42.21 | 27.43 | 8.09 | 7.94 | 6.82 | 0 | 1.52 | 2.55 | 3.27 | 1.7 | Upgrade
|
| Other Current Liabilities | 162.4 | 134.78 | 96.76 | 77.34 | 48.79 | 10.86 | 2.26 | -23.49 | -0.72 | 4.25 | Upgrade
|
| Total Current Liabilities | 214.92 | 183.23 | 149.77 | 130.8 | 106.48 | 60.32 | 42.89 | 28.51 | 18.64 | 6.76 | Upgrade
|
| Long-Term Debt | 290.29 | 215.02 | 103.32 | 81.67 | 89.13 | 0 | 0 | 1.52 | 4.07 | 7.34 | Upgrade
|
| Other Long-Term Liabilities | 413.43 | 436.97 | 28.41 | 35.83 | 47.73 | 60.79 | 48.88 | 39.69 | 12.21 | 115.21 | Upgrade
|
| Total Long-Term Liabilities | 703.72 | 651.99 | 131.73 | 117.5 | 136.85 | 60.79 | 48.88 | 41.21 | 16.28 | 122.54 | Upgrade
|
| Total Liabilities | 918.64 | 835.23 | 281.49 | 248.31 | 243.34 | 121.12 | 91.77 | 69.72 | 34.92 | 129.31 | Upgrade
|
| Total Debt | 332.5 | 242.45 | 111.41 | 89.6 | 95.95 | 0 | 1.52 | 4.07 | 7.34 | 9.04 | Upgrade
|
| Debt Growth | 37.14% | 117.62% | 24.33% | -6.61% | - | - | -62.69% | -44.55% | -18.85% | 215.82% | Upgrade
|
| Retained Earnings | -2,339.94 | -1,832.96 | -1,275.44 | -631.36 | -945.24 | -597.55 | -355.59 | -207.47 | -134.98 | -82.21 | Upgrade
|
| Comprehensive Income | -3.5 | -10.44 | -4.13 | -5.21 | -2.54 | -0.18 | -0.27 | -0.02 | 0 | 0 | Upgrade
|
| Shareholders' Equity | 130.61 | 514.68 | 970.74 | 1,470 | 464.36 | 419.01 | 623.97 | 213.08 | 143.98 | -79.38 | Upgrade
|
| Net Cash / Debt | 388.38 | 707.74 | 370.88 | 787.41 | 392.77 | 499.17 | 676.39 | 211.36 | 156.75 | 38.39 | Upgrade
|
| Net Cash / Debt Growth | -45.12% | 90.83% | -52.90% | 100.48% | -21.31% | -26.20% | 220.02% | 34.83% | 308.35% | - | Upgrade
|
| Net Cash Per Share | 6.41 | 11.87 | 6.34 | 14.02 | 8.21 | 11.38 | 17.90 | 7.69 | 8.60 | 27.01 | Upgrade
|
| Working Capital | 593.47 | 863.42 | 404.26 | 796.96 | 410.3 | 439.46 | 642.62 | 191.91 | 151.78 | 41.51 | Upgrade
|
| Book Value Per Share | 2.16 | 8.63 | 16.59 | 26.96 | 9.71 | 9.55 | 16.51 | 7.75 | 7.89 | -55.86 | Upgrade
|